Sidra Medicine, a member of Qatar Foundation, has signed a memorandum of understanding (MoU) with Germany-based Vitafluence.ai GmbH. They have also partnered with its Swiss venture studio, EmpathicAI.Life, to explore potential collaborations in artificial intelligence (AI) and digital health innovation.
The MoU sets the framework for a three-year collaboration aimed at jointly developing initiatives to enhance AI-powered healthcare delivery. It also aims to foster innovation within Sidra Medicine’s academic medical ecosystem. The agreement includes plans for pilot programmes, knowledge exchange, and co-development of digital solutions. These initiatives will support clinical decision-making and personalize patient care.
Dr. Tinubu-Karch stated, “Our joint research, clinical, and medical education programmes are designed to embrace emerging technologies that can revolutionise diagnostics, treatment, and patient care. Working with Vitafluence.ai gives us the opportunity to explore a range of AI-driven applications. These include predictive modelling, AI-assisted diagnostics, and tailored treatment pathways that align with our mission of delivering world-class precision medicine.”
She added, “Vitafluence.ai brings deep expertise in developing proprietary AI models and platforms that power data-driven decision-making in healthcare and life sciences.”
